IC-OS Weekly Webinar - Evaluation and Management of Cardiotoxicity from Radiation Therapy
Details
Organised by
Date
- America/New_York
Arco Teske
Dr A.J. Teske is a clinical cardiologist with focus on non-invasive imaging, heart valve diseases...
Read MoreDr A.J. Teske is a clinical cardiologist with focus on non-invasive imaging, heart valve diseases and he serves as the head of the echo-department at the University Medical Center Utrecht. He is the founder and current director of the University Utrecht Cardio-oncology Center of Excellence. His research focus is on advanced echocardiographic imaging and cardio-oncology.
Show LessDaniel Lenihan
Dr Lenihan has been active in cardio-oncology and heart failure, for over 20 years. The main...
Read MoreDr Lenihan has been active in cardio-oncology and heart failure, for over 20 years. The main focus of these efforts have included hemodynamic assessments, angiogenic growth factor response, novel cardiac biomarkers as well as optimal methods to prevent or detect heart failure at the earliest stage possible in patients undergoing treatment for cancer. His current research projects include early phase clinical trials in cardio-oncology, heart failure and amyloidosis. He is the Principal Investigator of the PROTECT study looking at cardiac safety in patients undergoing proteasome inhibitor treatment for relapsed multiple myeloma and the recently completed PREDICT study, a large multicenter prospective study examining the role of cardiac biomarkers for the detection of cardiotoxicity during anthracycline based therapy. In addition, he is intimately involved in the latest treatment trials for cardiac amyloidosis. He was recently at Washington University in St Louis to enhance and expand the Cardio-Oncology Center of Excellence. He is at the forefront of concerted efforts to develop a viable Cardio-Oncology fellowship training program and continues to foster collaboration among a host of colleagues both regionally, nationally, and throughout the world. He is the current President of the International Cardio-Oncology Society (ICOS),www.IC-OS.org, which is an international professional association whose primary goal is to eliminate cardiac disease as a barrier to effective cancer therapy.
Show LessHector Villarranga
Dr. Hector R. Villarraga is a cardiologist at the Mayo Clinic in Rochester, Minnesota. He is an...
Read MoreDr. Hector R. Villarraga is a cardiologist at the Mayo Clinic in Rochester, Minnesota. He is an Associate Professor of Medicine at the College of Medicine Mayo Clinic. He is board certified in Cardiovascular Diseases, Internal Medicine, and Echocardiography. His research interests include evaluation of myocardial mechanical function by speckle tracking echocardiography (strain) in cardiomyopathies with normal ejection fraction and in cardio-oncology. His other interests include developing artificial intelligence platforms for the diagnosis of cardiomyopathies, as well as, the applicability of virtual reality for complex valve structural cases. He is a member of the Cardio-Oncology Section Leadership Council, an elected member of the CardioSurve research panel of American College of Cardiology, and a member of the Academic JACC Publications work group. He is a former member of the American Society of Echocardiography Research Committee and ASE Writing Group for the consensus on the echocardiographic evaluation and treatment of adult patients during and after cancer therapy. He is an active member of American College of Cardiology, American Heart Association, American Society of Echocardiography, and American Society for Preventive Cardiology. Current prospective trials include evaluation of early cardiotoxicity in patients with lymphoma, breast cancer, sarcoma, and patients undergoing proton and photon radiotherapy.
Show LessJoseph Carver
Joseph R. Carver, MD, FACC is a Board Certified cardiologist. He is the Founding Editor of the...
Read MoreJoseph R. Carver, MD, FACC is a Board Certified cardiologist. He is the Founding Editor of the American Journal of Managed Care and was a Senior Corporate Medical Director at Aetna U.S. Healthcare from 1992-2001 where he was responsible for new program development and directed the National Medical Excellence Program. From 1999-2001, he was Co-chairperson of the New Jersey and Michigan Working Groups that established voluntary agreements among the insurers in those states to cover the routine costs of clinical trial participation for cancer patients. He is one of the Founding Editors of Cardio-oncology Journal. He currently is the Bernard Fishman Clinical Professor of Medicine at the Abramson Cancer Center of the University of Pennsylvania, the Chief Operating Officer of the Abramson Family Cancer Research Institute of the Abramson Cancer Center of the University of Pennsylvania and the Chief of Staff of the Abramson Cancer Center. He is the Director of the Thalheimer Cardio-oncology Center at the Abramson Cancer Center and his clinical practice is in the subspecialty of Cardio-oncology. He was the recipient of the IS Ravdin Master Clinician Award at Penn in 2012 and is one of the founding members of Penn Medicine’s Academy of Master Clinicians. He received the Thomas Force Award in 2020.
Show LessJoshua Mitchell
Joshua Mitchell, MD, MSCI is an Assistant Professor of Medicine and Director of the...
Read MoreJoshua Mitchell, MD, MSCI is an Assistant Professor of Medicine and Director of the Cardio-Oncology Fellowship at the Cardio-Oncology Center of Excellence, Washington University School of Medicine in St. Louis. Prior to coming to Washington University in 2015, he served 11 years in the US Army, deploying with the 82nd Airborne Division and the 75th Ranger Regiment, earning two Bronze Start Medals, and reaching the rank of Major. He is currently a member of the ICOS Scientific Committee and recently helped lead the 2021 ICOS expert consensus statement for cardiovascular disease screening in radiation survivors. He also serves on the JACC:Cardio-Oncology editorial board and is the Co-Chair for the ACC Cardio-Oncology working group. His clinical and research interests include better characterizing and understanding cardiovascular disease associated with cancer treatment, and the diagnosis of management of cardiac amyloidosis. His research has also focused on the use of coronary artery calcium to improve risk prediction and help target preventive therapy. As the Cardio-Oncology fellowship director at Washington University in St. Louis, he has directed the training and development for full year fellows, rotations for internal cardiology fellows, and rotations for both external cardiology fellows and for board certified cardiologists looking for additional training in Cardio-Oncology to improve their practice.
Show LessSarju Ganatra
Dr Ganatra serves as a Director of the Cardio-Oncology Program and Co-Director of the Cardiac MRI...
Read MoreDr Ganatra serves as a Director of the Cardio-Oncology Program and Co-Director of the Cardiac MRI Program for Lahey Hospital and Medical Center, Beth Israel Lahey Health in Boston. His primary research interest is outcomes research in cardio-oncology. He serves on the Research and Scientific Committee of the International Cardio-Oncology Society (ICOS), the American College of Cardiology Cardio-Oncology leadership council, and on the editorial board of JACC Cardio-Oncology.
Show Less